• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Non-uremic Calciphylaxis: A Rare and Late Adverse Reaction of Warfarin.非尿毒症性钙化防御:华法林一种罕见的迟发性不良反应。
Curr Drug Saf. 2019;14(3):246-248. doi: 10.2174/1574886314666190304094407.
2
Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy.华法令治疗后出现非典型钙化防御,停止华法令治疗并应用高压氧治疗后缓解。
Clin Appl Thromb Hemost. 2010 Jun;16(3):345-50. doi: 10.1177/1076029609355588. Epub 2009 Dec 16.
3
Breast fat necrosis secondary to warfarin-induced calciphylaxis, a rare mimicker of breast cancer: A case report and a review of literature.华法林诱导钙磷沉积症继发乳腺脂肪坏死,一种罕见的乳腺癌模拟疾病:病例报告及文献复习。
Breast J. 2021 Mar;27(3):258-263. doi: 10.1111/tbj.14160. Epub 2021 Jan 21.
4
Warfarin-induced calciphylaxis successfully treated with sodium thiosulphate.硫代硫酸钠成功治疗华法林诱导的钙化防御。
Australas J Dermatol. 2013 May;54(2):133-5. doi: 10.1111/j.1440-0960.2011.00861.x. Epub 2012 Feb 16.
5
Warfarin-Associated Nonuremic Calciphylaxis.华法林相关性非尿毒症性钙化防御
JAMA Dermatol. 2017 Mar 1;153(3):309-314. doi: 10.1001/jamadermatol.2016.4821.
6
Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1-34)] therapy in the setting of chronic warfarin and glucocorticoid treatment.在慢性华法林和糖皮质激素治疗背景下,特立帕肽[重组人甲状旁腺激素(1-34)]治疗引发的非尿毒症性钙化防御。
Osteoporos Int. 2014 Apr;25(4):1411-4. doi: 10.1007/s00198-013-2580-6. Epub 2013 Nov 29.
7
Calciphylaxis in a cardiac patient without renal disease.一名无肾脏疾病的心脏病患者发生了钙过敏。
Acta Cardiol. 2009 Feb;64(1):91-3. doi: 10.2143/AC.64.1.2034368.
8
Warfarin-induced pulmonary metastatic calcification and calciphylaxis in a patient with end-stage renal disease.华法林诱导的终末期肾病患者肺转移性钙化和钙化防御。
Chest. 2011 Jun;139(6):1503-1506. doi: 10.1378/chest.10-1322.
9
Calciphylaxis in the Setting of Hemodialysis, Liver Cirrhosis, and Warfarin Therapy for Atrial Fibrillation: An Argument for Alternative Anti-Embolic Therapy.血液透析、肝硬化及华法林治疗心房颤动背景下的钙化防御:支持替代抗栓治疗的理由
Cureus. 2020 May 7;12(5):e8014. doi: 10.7759/cureus.8014.
10
Case Report of Calciphylaxis Secondary to Calcium and Vitamin D Supplementation.补钙和维生素D继发钙化防御的病例报告
J Cutan Med Surg. 2017 Mar/Apr;21(2):162-163. doi: 10.1177/1203475416668162. Epub 2016 Sep 21.

本文引用的文献

1
Calciphylaxis.钙过敏症
N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292.
2
A Case of Nonuremic Calciphylaxis in a Caucasian Woman.一名白人女性的非尿毒症性钙化防御病例。
Case Rep Dermatol Med. 2017;2017:6831703. doi: 10.1155/2017/6831703. Epub 2017 Jan 16.
3
Warfarin-Associated Nonuremic Calciphylaxis.华法林相关性非尿毒症性钙化防御
JAMA Dermatol. 2017 Mar 1;153(3):309-314. doi: 10.1001/jamadermatol.2016.4821.
4
Warfarin-induced calciphylaxis.华法林所致钙化防御。
BMJ Case Rep. 2016 Jan 18;2016:bcr2015214142. doi: 10.1136/bcr-2015-214142.
5
Calciphylaxis: risk factors, diagnosis, and treatment.钙过敏症:危险因素、诊断与治疗
Am J Kidney Dis. 2015 Jul;66(1):133-46. doi: 10.1053/j.ajkd.2015.01.034. Epub 2015 May 7.
6
Warfarin-induced calciphylaxis: a case report and review of literature.华法林诱导的钙化防御:病例报告及文献复习。
Int J Gen Med. 2013 Aug 9;6:665-9. doi: 10.2147/IJGM.S47397. eCollection 2013.

非尿毒症性钙化防御:华法林一种罕见的迟发性不良反应。

Non-uremic Calciphylaxis: A Rare and Late Adverse Reaction of Warfarin.

作者信息

Patel Dhruvkumar M, Patel Mukundkumar V, Patel Akash D, Kaklotar Jignesh C, Patel Greshaben R, Patel Maitri M

机构信息

N.H.L. Municipal Medical College, Ahmedabad, Gujarat, India.

Zydus Medical College and Hospital, Dahod, Gujarat, India.

出版信息

Curr Drug Saf. 2019;14(3):246-248. doi: 10.2174/1574886314666190304094407.

DOI:10.2174/1574886314666190304094407
PMID:30834840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6864595/
Abstract

BACKGROUND

Calciphylaxis is a complex dermatological lesion of micro vascular calcification that is typically presented as panniculitis with gangrenous painful lesions having uremic and non-uremic causes.

CASE REPORT

We present a case of a 48-year old male with a history of paroxysmal atrial fibrillation and hypertension taking amlodipine 5 mg and warfarin 5 mg daily for the last 26 months. The patient had a 6- months history of painful swelling followed by necrotic skin ulcer over the right leg. His remarkable examination findings were right leg tender ulcer with surrounding erythema and secondary sepsis. His hemogram, metabolic profile and connective tissue diseases work up were unremarkable except leucocytosis and raised inflammatory markers. His local part radiological and skin biopsy findings were suggestive of calciphylaxis.

RESULTS AND CONCLUSION

In our case, warfarin and amlodipine were culprit drugs for the lesion, but Naranjo score (warfarin 7and amlodipine 1) speculate warfarin as a probable adverse reaction of warfarin. The lesion was cured with local wound treatment after discontinuation of warfarin. The physician should be aware of this rare cutaneous disorder of systemic origin for proper management.

摘要

背景

钙化防御是一种微血管钙化的复杂皮肤病损,通常表现为脂膜炎,伴有坏疽性疼痛性皮损,病因包括尿毒症性和非尿毒症性。

病例报告

我们报告一例48岁男性,有阵发性心房颤动和高血压病史,在过去26个月中每天服用5毫克氨氯地平和5毫克华法林。患者有6个月的右下肢疼痛性肿胀病史,随后出现坏死性皮肤溃疡。其显著的检查结果为右下肢压痛性溃疡,周围有红斑及继发性脓毒症。除白细胞增多和炎症标志物升高外,其血常规、代谢指标及结缔组织病检查均无异常。其局部放射学及皮肤活检结果提示钙化防御。

结果与结论

在我们的病例中,华法林和氨氯地平是导致该病变的罪魁祸首药物,但根据纳兰霍评分(华法林评分为7,氨氯地平评分为1)推测华法林是可能的不良反应原因。停用华法林后,通过局部伤口治疗,病变得以治愈。医生应了解这种罕见的全身性皮肤疾病以便进行恰当处理。